Topic: biomedical research
Trump’s budget proposals for 2020 are in, seeking a cut for the NIH for the third year in a row but an increase in the FDA’s finances.
Microsoft is bringing its coding skills to bear on biotech, with the goal of building a platform for programming the biology of living cells.
Amicus plans to build an R&D center in the heart of Philadelphia’s University City, not long after inking a $100 million deal for 10 gene therapies.
Charles River has added another string to its early-stage R&D bow by acquiring preclinical services firm Citoxlab for $510 million in cash.
Johnson & Johnson Innovation joined a medical device incubator backed by Deerfield while making an investment of its own through J&J’s venture arm.
Join as Diane Hayes, PHD, InCrowd President and Co-founder, reviews the results from the 2019 physician predictions survey and considers the year ahead.
This webinar will provide a PoV on R&D Operations from notable industry leaders with over 20+ years of experience designing, building and implementing R&D Operations capabilities within our industry.
Sanofi and Sema4 launched a five-year study of nearly 1,200 asthma patients, incorporating digital tools to better understand the disease.
In a collaboration worth up to $300 million or more, Boehringer Ingelheim tapped Epizyme to help research two regulators of genes linked to cancer.
AbbVie has signed on to be the first tenant at a new biotech campus in South San Francisco.